| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59603c0097795b191b1607cc90087f63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c213ba9952360f439567152e047b18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77288ad1cc75b296822a4c0c940a8cbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f477d7ed29723854e4f6b159f0c689b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-624 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 |
| filingDate |
2008-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f61eb789e99743d4dc0885f5989811d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e08a9a26667245bc184879466134ce04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8b38b9f80ff29e5de865d238a7e4167 |
| publicationDate |
2008-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008109347-A2 |
| titleOfInvention |
Methods for ex vivo administration of drugs to grafts using polymeric nanoparticles |
| abstract |
Methods for ex vivo administration of drugs to grafts using polymeric micro- and nanoparticles and applications for these methods are described herein. The particles contain encapsulated molecules which are released locally at the site of implantation and function to prevent graft rejection or aid in the proper adaptation of the graft to the host. The disclosed methods may be used to inhibit or reduce hyperplasia and stenosis of vascular grafts or to prevent graft rejection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10555948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014165679-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3116392-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265407-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3760223-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9539217-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071776-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9597385-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9999600-B2 |
| priorityDate |
2007-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |